Thanks for your perspective on the single most important aspect of Recaf and reminding us why we invested in Biocurex. I've been of the opinion for some time at this stage of their progress, we shouldn't be too concerned about the current share price of Biocurex. Biocurex will continue to trade at this range until the company has a steady revenue stream or signs another license agreement. Investors should view this as an ideal time to pick up cheap shares if they truly beleive in the technology. I would also like to remind investors, during April, 2001, the share price increased from less than .50/share to $5.75/share, solely on a press release. Imagine what will happen to the share price once Biocurex actually has a steady revenue stream which is Dr. Moro's top priority.

Dr, Moro is a lot further along toward his ultimate goal of commercializing Recaf than he was 8 years ago. It's very easy to attack/discredit any progress or milestones that Dr. Moro has achieved toward that goal since he is restricted from disclosing sensitive information to shareholders at this time.

I remember a few years ago several people (bashers) claiming Dr. Moro would never sign a license agreement with another Biotech company. That's was two license agreements ago. Oh well, I guess they were wrong. As Dr. Moro stated in the past, we have to trust him to deliver on his promises. I look forward to the day we reap the benefits of our patience and Dr. Moro and his dedicated employees hard work.

JMHO